A recent ruling by the Regional Court of Düsseldorf has determined that Pfizer and its German collaborator BioNTech must compensate Moderna, assisted by Freshfields, for utilizing its European Patent 949 (EP 949), marking a significant development
Tags :pfizer
Leading figures from two British intellectual property organizations have addressed concerns to a Unified Patent Court (UPC) appeal judge regarding a ruling that could block corporate lawyers and patent attorneys from client representation at the
German immunotherapy and pharmaceutical company BioNTech and its US partner Pfizer, producers of one of the Covid-19 vaccines, are trying to invalidate two patents owned by their competitor Moderna in front of the US Patent
